News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|March 7, 2021

Educated Patient® Breast Cancer Summit: March 7, 2021

Author(s)CURE staff

View the full CURE Educated Patient Breast Cancer Summit on demand.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
breast cancer

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

ByCURE staff
January 30th 2026
Bonnie Annis

The Last Walk Down the Hall: Reflections Before Entering Cancer Survivorship

ByBonnie Annis
January 30th 2026
breast cancer

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

ByCURE staff
January 30th 2026
breast cancer

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

ByCURE staff
January 29th 2026
Dr. Anne Peled

Breast Cancer Surgeon and Survivor Undergoes Nerve-Sparing Procedure

ByAlex Biese
January 27th 2026
Advertisement
Advertisement

Trending on CURE

1

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

2

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

3

FDA Accepts Ivonescimab Application for EGFR Lung Cancer

4

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

5

Key GI Cancer Advances from the 2026 ASCO Symposium

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.